Search research articles
Contact Us
Filters
Showing results (21-30 of 358) with videos related to
Page
of 36
Sort By:
Vitamins and Hormones
|
April 28, 2004
FLIP protein and TRAIL-induced apoptosis
Wilfried Roth, John C Reed
Cancer Research
|
October 4, 2016
Finally, An Apoptosis-Targeting Therapeutic for Cancer
Carlo M Croce, John C Reed
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2003
Cancer immunotherapy targeting survivin: commentary re: V. Pisarev et al., full-length dominant-negative survivin for cancer immunotherapy. Clin. Cancer Res., 9:6523-6533, 2003
John C Reed, Darcy B Wilson
Methods in Molecular Biology (Clifton, N.J.)
|
January 26, 2008
Yeast and mammalian two-hybrid systems for studying protein-protein interactions
Shu-ichi Matsuzawa, John C Reed
Current Drug Targets
|
May 12, 2004
CARD proteins as therapeutic targets in cancer
Jason S Damiano, John C Reed
Nature Structural Biology
|
December 26, 2001
Degrading liaisons: Siah structure revealed
John C Reed, Kathryn R Ely
Science'S STKE : Signal Transduction Knowledge Environment
|
May 23, 2002
TRAF1: lord without a RING
Juan M Zapata, John C Reed
The Biochemical Journal
|
October 25, 2017
Therapeutics targeting Bcl-2 in hematological malignancies
Astrid Ruefli-Brasse, John C Reed
Nature
|
June 10, 2011
NIH: translation centre bridges a gap
John C Reed, E Lucile White
Molecular Cell
|
January 24, 2002
Remodeling for demolition: changes in mitochondrial ultrastructure during apoptosis
John C Reed, Douglas R Green
Page
of 36
Search research articles
Search
Showing results (21-30 of 358) with videos related to
Sort By:
Page
of 36
Vitamins and Hormones
|
April 28, 2004
FLIP protein and TRAIL-induced apoptosis
Wilfried Roth, John C Reed
Cancer Research
|
October 4, 2016
Finally, An Apoptosis-Targeting Therapeutic for Cancer
Carlo M Croce, John C Reed
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2003
Cancer immunotherapy targeting survivin: commentary re: V. Pisarev et al., full-length dominant-negative survivin for cancer immunotherapy. Clin. Cancer Res., 9:6523-6533, 2003
John C Reed, Darcy B Wilson
Methods in Molecular Biology (Clifton, N.J.)
|
January 26, 2008
Yeast and mammalian two-hybrid systems for studying protein-protein interactions
Shu-ichi Matsuzawa, John C Reed
Current Drug Targets
|
May 12, 2004
CARD proteins as therapeutic targets in cancer
Jason S Damiano, John C Reed
Nature Structural Biology
|
December 26, 2001
Degrading liaisons: Siah structure revealed
John C Reed, Kathryn R Ely
Science'S STKE : Signal Transduction Knowledge Environment
|
May 23, 2002
TRAF1: lord without a RING
Juan M Zapata, John C Reed
The Biochemical Journal
|
October 25, 2017
Therapeutics targeting Bcl-2 in hematological malignancies
Astrid Ruefli-Brasse, John C Reed
Nature
|
June 10, 2011
NIH: translation centre bridges a gap
John C Reed, E Lucile White
Molecular Cell
|
January 24, 2002
Remodeling for demolition: changes in mitochondrial ultrastructure during apoptosis
John C Reed, Douglas R Green
Page
of 36